Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries Ltd (NY: TEVA )

10.84 USD -0.04 (-0.36%)
Streaming Delayed Price Updated: 1:09 PM EDT, Apr 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Teva Pharmaceutical Industries Ltd

< Previous 1 2 3 4 5 6 7 8 9
...
76 77 Next >
R&D Leading to Supported Progress For Treating Acute Myeloid Leukemia (AML)
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
R&D Leading to Supported Progress for Treating Acute Myeloid Leukemia (AML)
Financialnewsmedia.com News Commentary 
From PR Newswire
Teva Announces Positive Top-Line Results from AJOVY® (fremanezumab) Clinical Trials in Japan
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced positive results from two Phase 2/3 trials evaluating AJOVY® (fremanezumab) in patients in Japan. AJOVY is under development in... 
From Business Wire News Releases
Teva Announces FDA Approval of AJOVY® (fremanezumab-vfrm) Injection Autoinjector
Teva Pharmaceuticals USA, Inc. an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the Food and Drug Administration (FDA) has approved an autoinjector device... 
From Business Wire News Releases
Teva to Host Conference Call to Discuss Fourth Quarter 2019 Financial Results and 2020 Financial Guidance at 8 a.m. ET on February 12, 2020
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it will issue a press release on its fourth quarter and full year 2019 financial results, as well as on its financial... 
From Business Wire News Releases
Teva to Present at the 38th Annual J.P. Morgan Healthcare Conference
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that President & CEO Kåre Schultz will present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco,... 
From Business Wire News Releases
NexImmune Appoints Sol Barer as Chairman of the Board of Directors
From GlobeNewswire News Releases
Thinking about buying stock in Apple, General Electric, Macy's, Nio, or Teva Pharmaceutical?
InvestorsObserver issues critical PriceWatch Alerts for AAPL, GE, M, NIO, and TEVA. 
From PR Newswire
Teva Announces Early Tender Results of its Debt Tender Offer and Election of Early Settlement
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today the early tender results in connection with its previously announced tender offers (the “Offers”) to purchase for cash... 
From Business Wire News Releases
Teva Announces Successful Upsize of Senior Notes Offering and Pricing of $2.1 Billion of Senior Notes
Teva Pharmaceutical Industries Limited (NYSE and TASE: TEVA) (“Teva”) announced today that it successfully upsized and priced approximately $2.1 billion (equivalent) of its senior notes (the “Notes”).... 
From Business Wire News Releases
Why Oncology Drugs Are Projected to Generate the Largest Pharma Revenues
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Why Oncology Drugs are Projected to Generate the Largest Pharma Revenues
Financialnewsmedia.com News Commentary 
From PR Newswire
Thinking about buying stock in Aurora Cannabis, Advanced Micro Devices, General Electric, Teva Pharmaceutical, or Uber Technologies?
InvestorsObserver issues critical PriceWatch Alerts for ACB, AMD, GE, TEVA, and UBER. 
From PR Newswire
Teva Announces $1.5 Billion Debt Tender Offers
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it has commenced tender offers (the “Offers”) to purchase for cash for a combined aggregate purchase price (exclusive of... 
From Business Wire News Releases
Teva Announces Launch of $1,500,000,000 Offering of Senior Notes
Teva Pharmaceutical Industries Limited (NYSE and TASE: TEVA) (“Teva”) announced today the following private offering of senior notes: 
From Business Wire News Releases
NYSE: TEVA Long Term Investor Alert: Investigation of Potential Wrongdoing at Teva Pharmaceutical Industries Limited
San Diego, CA -- (SBWIRE) -- 11/07/2019 -- Certain directors of Teva Pharmaceutical Industries Limited are under investigation concerning potential breaches of fiduciary duties. 
From SBWire - Latest Press Releases
Thinking about buying stock in Advanced Micro Devices, General Electric, QUALCOMM, Teva Pharmaceutical, or Uber Technologies?
InvestorsObserver issues critical PriceWatch Alerts for AMD, GE, QCOM, TEVA, and UBER. 
From PR Newswire
Teva and Celltrion Announce the Availability of TRUXIMA® (rituximab-abbs) Injection, the First Biosimilar to Rituxan® (rituximab) in the United States
Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), Celltrion, Inc., (KRX KRX:068270) and Celltrion Healthcare, Co., Ltd. (KRX KOSDAQ:091990),... 
From Business Wire News Releases
Teva Announces Appointment of New Chief Financial Officer
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today the appointment of Eli Kalif as Executive Vice President and Chief Financial Officer. Mr. Kalif will begin his employment on... 
From Business Wire News Releases
Teva Reports Third Quarter 2019 Financial Results
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) today reported results for the quarter ended September 30, 2019. 
From Business Wire News Releases
Teva to Host Conference Call to Discuss Third Quarter 2019 Financial Results at 8 a.m. ET on November 7, 2019 (Updated Dial-in Information)
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it will issue a press release on its third quarter 2019 financial results on Thursday, November 7, 2019 at 7:00 a.m. ET.... 
From Business Wire News Releases
Teva Canada Announces the Launch of a Bioequivalent Generic Version of [Pr]Gilenya®, [Pr]Teva-Fingolimod Capsules for the treatment of Relapsing-Remitting Multiple Sclerosis (MS)
From PR Newswire
Teva to Present New Analyses of Fremanezumab and Country-Specific Burden of Migraine at 24th World Congress of Neurology
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that 12 new analyses will be presented at the 24th World Congress of Neurology (WCN), taking place in Dubai, United Arab... 
From Business Wire News Releases
Teva Settles Track 1 Opioid Cases and Reaches Agreement on Framework to Settle Remaining Litigation
Teva Pharmaceutical Industries Ltd. and its affiliates today announced a settlement agreement with both Cuyahoga and Summit counties of Ohio. The settlement resolves the counties’ claims and removes... 
From Business Wire News Releases
Lifshitz & Miller LLP Announces Investigation of Allegiant Travel Company, AMC Entertainment Holdings, Inc., Aqua Metals, Inc., CenturyLink, Inc., IVERIC bio, Inc., and Teva Pharmaceutical Industries
From PR Newswire
Teva to Host Conference Call to Discuss Third Quarter 2019 Financial Results at 8 a.m. ET on November 7, 2019
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it will issue a press release on its third quarter 2019 financial results on Thursday, November 7, 2019 at 7:00 a.m. ET.... 
From Business Wire News Releases
Teva to Present New Data on AUSTEDO® (deutetrabenazine) Tablets at Psych Congress 2019
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that new AUSTEDO® (deutetrabenazine) data will be presented at the 32nd annual Psych Congress, October 3-6, 2019 in San Diego,... 
From Business Wire News Releases
Teva Announces Leadership Change in its Global Operations Group
Teva Pharmaceutical Industries (NYSE and TASE: TEVA) announced today the retirement of Dr. Carlo de Notaristefani, and the appointment of Eric Drapé as Executive Vice President, Global Operations. Dr.... 
From Business Wire News Releases
INTERCURE: CANNDOC signs strategic distribution agreement with S.L.E. of TEVA Pharmaceuticals
InterCure (TASE: INCR), announced that subsidiary Canndoc has entered into a strategic distribution agreement with Salomon, Levin, Elstein (S.L.E.,) which is owned by Teva Pharmaceuticals Industries... 
From PR Newswire
Teva Announces United States Department of Commerce Appointment of Brendan O’Grady to Investment Advisory Council
Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today announced that the U.S. Department of Commerce has selected Brendan O’Grady, Executive Vice President and Head of North America Commercial to... 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
76 77 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account